Orthofix Medical Inc. (OFIX) — Analyst outlook / Analyst consensus target is. Based on 17 analyst ratings, the consensus is bullish — 7 Buy, 9 Hold, 1 Sell.
The consensus price target is $20.00 (low: $18.00, high: $22.00), representing an upside of 57.2% from the current price $12.72.
Analysts estimate Earnings Per Share (EPS) of $-2.83 and revenue of $0.80B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-3.30 vs est $-2.83 (missed -16.5%). 2025: actual $-2.28 vs est $-2.26 (missed -0.9%). Analyst accuracy: 92%.
OFIX Stock — 12-Month Price Forecast
$20.00
▲ +57.23% Upside
Average Price Target
Based on 17 Wall Street analysts offering 12-month price targets for Orthofix Medical Inc., the average price target is $20.00, with a high forecast of $22.00, and a low forecast of $18.00.
The average price target represents a +57.23% change from the last price of $12.72.
Highest Price Target
$22.00
Average Price Target
$20.00
Lowest Price Target
$18.00
OFIX Analyst Ratings
Hold
Based on 17 analysts giving stock ratings to Orthofix Medical Inc. in the past 3 months
EPS Estimates — OFIX
92%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$3.30
vs Est –$2.83
▼ 14.2% off
2025
Actual –$2.28
vs Est –$2.26
▼ 0.9% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
Revenue Estimates — OFIX
99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.799B
vs Est $0.796B
▲ 0.4% off
2025
Actual $0.822B
vs Est $0.814B
▲ 1.0% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
